Stock Events

 

kr0.31
1157
+kr0+0% Today

Statistics

Day High
0.31
Day Low
0.3
52W High
0.56
52W Low
0.18
Volume
303,309
Avg. Volume
1,005,110
Mkt Cap
245.51M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29AugConfirmed
Q1 2024
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PEG.CO. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Vanguard High Dividend Yield Indx
VYM
Mkt Cap55.2B
Vanguard High Dividend Yield ETF offers a similar focus on high dividend yield stocks, making it a direct competitor.
iShares Select Dividend
DVY
Mkt Cap18.76B
iShares Select Dividend ETF is focused on dividend yield, directly competing for investors seeking income through dividends.
SPDR Dividend
SDY
Mkt Cap20.13B
SPDR S&P Dividend ETF targets high dividend yield companies in the S&P, similar to Guggenheim's dividend-focused strategy.
iShares Core High Dividend
HDV
Mkt Cap10.37B
iShares Core High Dividend ETF offers exposure to high dividend paying U.S. equities, competing in the same space.
Schwab US Dividend Equity
SCHD
Mkt Cap56.22B
Schwab U.S. Dividend Equity ETF is focused on high dividend yielding stocks, making it a competitor.
iShares Core Dividend Growth
DGRO
Mkt Cap28.08B
iShares Core Dividend Growth ETF focuses on companies with a history of dividend growth, appealing to similar investors.
ProShares S&P 500 Dividend Aristocrats
NOBL
Mkt Cap11.74B
ProShares S&P 500 Dividend Aristocrats ETF targets companies with a long history of increasing dividends, competing for dividend-focused investors.
Vanguard Dividend Appreciation FTF
VIG
Mkt Cap80.82B
Vanguard Dividend Appreciation ETF is focused on companies that have a record of growing their dividends, appealing to the same investor base.
WisdomTree U.S. Quality Dividend Growth Fund
DGRW
Mkt Cap13.69B
WisdomTree U.S. Quality Dividend Growth Fund is focused on dividend growth and quality, making it a direct competitor.
First Trust Value Line Dividend Index Fund
FVD
Mkt Cap9.38B
First Trust Value Line Dividend Index Fund seeks to invest in companies with high dividend yields, directly competing in the dividend-focused investment space.

About

Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which current therapy is lacking or in need of improvement. Its products under development that are in Phase II clinical trials include RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouchitis; and RNX-051 for the treatment of colorectal cancer and colon adenoma. The company was incorporated in 2002 and is based in Hørsholm, Denmark.
Show more...
CEO
Mr. Thomas Kaas Selsø
Country
Denmark

Listings